Search Results

FRAX597 2 mg  | 99.75%

TargetMol

FRAX597 is an effective, ATP-competitive inhibitor of group I PAKs, and for PAK1(IC50=8 nM), PAK2(IC50=13 nM), and PAK3 (IC50=19 nM).

More Information Supplier Page

COTI-2 25 mg  | 99.49%

TargetMol

COTI-2, an orally available thiosemicarbazone, is an activator of mutant forms of the p53 protein with potential antineoplastic activity.

More Information Supplier Page

COTI-2 10 mg  | 99.49%

TargetMol

COTI-2, an orally available thiosemicarbazone, is an activator of mutant forms of the p53 protein with potential antineoplastic activity.

More Information Supplier Page

COTI-2 5 mg  | 99.49%

TargetMol

COTI-2, an orally available thiosemicarbazone, is an activator of mutant forms of the p53 protein with potential antineoplastic activity.

More Information Supplier Page

COTI-2 2 mg  | 99.49%

TargetMol

COTI-2, an orally available thiosemicarbazone, is an activator of mutant forms of the p53 protein with potential antineoplastic activity.

More Information Supplier Page

Hispidol 25 mg  | 100.00%

TargetMol

Hispidol ((Z)-Hispidol) is a potential therapeutic for inflammatory bowel disease; inhibits TNF-α induced adhesion of monocytes to colon epithelial cells with an IC50 of 0.50 μM.

More Information Supplier Page